Virus Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bird Flu
StormBio and Imperial Innovations Enter Agreement for Pandemic Influenza Treatment
April 10th, 2007
StormBio, Inc. and Imperial Innovations Group plc (Imperial Innovations), the technology commercialization and investment company based at Imperial College London, announced an agreement to license patents and know-how for development of a novel therapy for life-threatening influenza and other inflammatory diseases. This agreement will permit StormBio to develop a new class of therapeutics to save lives and reduce disability from flu and other inflammatory diseases. The StormBio therapeutic will differ from current influenza treatments by targeting the body's over-reaction of the inflammatory process, without shutting down the immune response. The...
Source: Virus Weekly (2007-04-10)
|
